Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 30;1(3):277-286.
doi: 10.1016/j.gastha.2022.01.001. eCollection 2022.

Patient and Endoscopic Characteristics of Postcolonoscopy Colon Cancer-A Case-control Study

Sonja P Dawsey  1 , Pamela M Vacek  2 , Eric K Ganguly  1
Affiliations

Patient and Endoscopic Characteristics of Postcolonoscopy Colon Cancer-A Case-control Study

Sonja P Dawsey et al. Gastro Hep Adv. .

Abstract

Background and aims: Colonoscopy is imperfect for colorectal cancer (CRC) prevention. Postcolonoscopy CRC (PCCRC) is defined as CRC detected after a screening or surveillance colonoscopy. PCCRCs can be divided into noninterval CRC and interval CRC. We performed a case-control study to identify risk factors for PCCRCs and to compare risks between noninterval and interval PCCRCs.

Methods: We designed a retrospective case-control study. Using a Vermont tumor registry data set, we identified all PCCRCs diagnosed at our medical center from January 2012 to September 2017. Cases were matched 1:3 with controls of the same age, sex, and index colonoscopy date.

Results: Fifty-four PCCRCs were matched with 162 controls and divided into noninterval (N = 27) and interval (N = 27) subsets. Overall PCCRC risk and noninterval PCCRC risk were significantly associated with history of polyps (odds ratio [OR] PCCRC = 2.71, OR noninterval = 4.41), sessile serrated polyps (OR PCCRC = 3.94, OR noninterval = 5.79), and high-risk adenoma (HRA) (OR PCCRC = 6.58, OR noninterval = 16.46) and with the index colonoscopy having a large polyp (OR PCCRC = 4.45, OR noninterval = 10.46) or having an HRA (OR PCCRC = 3.68, OR noninterval = 8.04). PCCRC risk and interval PCCRC risk were significantly associated with follow-up recommendations that did not correlate with American Gastroenterological Association surveillance guidelines (OR PCCRC = 3.30, OR interval = 4.85). Approximately 30% of PCCRCs could be attributed to endoscopic quality.

Conclusion: Overall PCCRC risk and noninterval PCCRC risk were significantly associated with traditional CRC risk factors including precancerous polyps and HRA on the index colonoscopy. Interval PCCRC was not associated with these risk factors. Many PCCRCs can be attributed to endoscopic quality, and nonadherence to CRC surveillance guidelines may be a novel risk factor.

Keywords: Colonoscopy; Colorectal Cancer Risk; Interval Cancer; Postcolonoscopy Colorectal Cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Definitions of PCCRC and its subdivisions of interval PCCRC and noninterval PCCRC with examples of each.
Figure 2
Figure 2
Plausible PCCRC etiologies as per the World Endoscopy Organization’s algorithm.
See this image and copyright information in PMC

References

    1. Howlader N., Noone A.M., Krapcho M., et al., editors. SEER cancer statistics review, 1975-2017, National Cancer Institute. Surveillance Research Program of the National Cancer Institute; Bethesda, MD: 2020.
    1. Zauber A.G., Winawer S.J., O'Brien M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696. - PMC - PubMed
    1. Rex D.K., Boland C.R., Dominitz J.A., et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2017;112:1016–1030. - PubMed
    1. Rabeneck L., Paszat L.F. Circumstances in which colonoscopy misses cancer. Frontline Gastroenterol. 2010;1:52–58. - PMC - PubMed
    1. Cooper G.S., Xu F., Barnholtz Sloan J.S., et al. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer. 2012;118:3044–3052. - PMC - PubMed

LinkOut - more resources